TAS102 in Combination With NAL-IRI in Advanced GI Cancers

Clinical trial NCT03368963 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03368963
Sponsor: Emory University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Adenocarcinoma Gastric Adenocarcinoma Metastatic Pancreatic Adenocarcinoma Non-Resectable Cholangiocarcinoma Stage IV Colorectal Cancer Stage IV Gastric Cancer Stage IV Pancreatic Cancer Stage IVA Colorectal Cancer Stage IVB Colorectal Cancer Stage III Colorectal Cancer Stage III Gastric Cancer Stage III Pancreatic Cancer

Start date: 2018-01-30
Primary completion: 2025-06-28
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.